|
||||||||||||||||||||
|
Catherine Lomen-Hoerth, M.D.,
Ph.D.
Assistant Professor in Residence, Department of Neurology I am an Assistant Professor in Residence in the Department of Neurology at the University of California, San Francisco where I have been on the faculty for 8 years. I currently direct the ALS Center at UCSF and the EMG fellowship program. I trained first at Stanford where I obtained MD and PhD degrees in Neuroscience in 1994 working in the laboratory of Dr. Eric Shooter. After pursuing a neurology residency at UCSF and finishing my last year as chief resident, I realized I wanted to integrate research and clinical practice in order to apply research more readily to patient care. Seeing first hand the rapid progression of ALS and the impact on patients’ lives motivated me to pursue a career in ALS clinical research. I wanted to impact the disease while maintaining close clinical contact with patients. My goals were to pursue clinical research while using my basic science background to collaborate with others to apply the advances in basic science to clinical research and vice versa. In order to fulfill the goal of pursuing ALS clinical research, I completed a clinical neurophysiology and neuromuscular disease fellowship at UCSF in 1999. During this fellowship, I learned the electrophysiological techniques needed for my clinical research and further developed my clinical skills in neuromuscular disease. During my fellowship I received the Golseth award for an outstanding research paper and was an invited lecturer to open the plenary session at the AAEM meeting in Vancouver. Obtaining a K23 grant and an AAN-ERF Clinical Research Fellowship in 1999 to study electrophysiological and genetic predictors of prognosis in ALS enabled me to start my faculty appointment at UCSF with 100% grant funding for my salary. Since that time, I have obtained several ALS association grant and am
involved in an NIH program project grant with Dr. Bruce Miller on frontotemporal
dementia. My current research focuses on environmental risk factors in
ALS, clinical drug trials, early detection of dementia in ALS, and neuroimaging
to predict prognosis. Outside of work, I enjoy hiking, cooking, and reading. I am involved
in medical missions both locally and abroad. |
|||||||||||||||||||
|
|